Benitec Biopharma Limited Stock Australian S.E.
Equities
BLT
AU000000BLT8
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 26.85M 17.46M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.74
x | P/E ratio 2025 * |
-3.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.88% |
Managers | Title | Age | Since |
---|---|---|---|
Jerel Banks
CEO | Chief Executive Officer | 49 | 16-09-30 |
Peter Roelvink
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-28 |
Megan Boston
CMP | Compliance Officer | 52 | 16-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Buchi
BRD | Director/Board Member | 69 | 13-03-31 |
Edward Smith
BRD | Director/Board Member | 53 | 20-04-13 |
Peter Francis
BRD | Director/Board Member | 68 | 06-01-31 |
1st Jan change | Capi. | |
---|---|---|
+0.73% | 43.84B | |
+5.52% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.21% | 25.53B | |
-25.11% | 18.18B | |
-3.42% | 12.29B | |
+26.52% | 12.29B | |
+6.63% | 11.15B |